There are approximately 100 000 first strokes per gests antihypertensive therapy reduces stroke recurrence by 38%. 9 Furthermore a large Chinese study year in the UK. Estimates of the risk of stroke recurrence in the first year varies from 10-20% with (the Post-stroke Antihypertensive Treatment Study) of indapamide in hypertensive and normotensive approximately an annual risk of 5-10% thereafter. Reducing this risk is the prime concern of stroke sufpatients reported a 29% reduction in stroke recurferers, preventing stroke recurrence and other manirence. 10 However, the median time from first stroke festations of vascular disease should therefore be of to study entry was 14 months, mean age was 60 high priority. Unfortunately there are few strategies years and most participants had made a good or total for reducing stroke recurrence at present that are recovery. The risks and benefits of antihypertensive widely applicable; one area where doctors feel that therapy in the large number of older and frailer they can intervene is in the treatment of high blood stroke patients commonly seen in our hospitals pressure (BP). There is good evidence for primary remain largely unresolved. prevention of stroke in persons up to 80 years with A further consideration, highlighted by Azuma et antihypertensive therapy where risk reductions of al 11 in this edition of the Journal, is the relevance of up to 40% are reported. Can this evidence be used circadian BP variability to vascular disease and the uncritically to justify treatment in patients who have effect of antihypertensive agents on it. There have already suffered a stroke? Such patients, because of been many reports correlating the time of vascular their ischaemic neuronal damage, intra and/or extra events with circadian changes in biological variables cranial vessel disease may differ importantly from such as BP. The morning or awakening surge in BP the bulk of those patients recruited to the primary and sympathetic tone has been thought responsible prevention trials. The risks and benefits of antifor the morning increase in myocardial infarction hypertensive therapy may not be the same. and stroke. 12 More recently the presence (dipper) or High BP is common acutely following stroke absence (non-dipper) of the physiological nocturnal, when 70% of patients have BP у 170/110 mm Hg, 1 or sleep induced, fall in BP has been associated with but falls spontaneously in the first few days, 2 the prevalence of vascular disease including stroke. although the prevalence of hypertension after this
In cross-sectional studies 13-15 and a longitudinal time remains high at approximately 50%. However, study 16 a reduced nocturnal compared to diurnal BP high BP following stroke has not consistently been has been associated with a greater risk of hypertenfound to be a risk factor for stroke recurrence 3-6 and sive end organ and vascular damage including some studies have reported a J-curve relationship stroke. Yet others have reported that a greater amplibetween post-stroke BP and outcome. 7 However, tude of nocturnal BP fall is directly correlated with analysis of the UK-TIA aspirin trial which included the severity of silent cerebrovascular lesions in eldonly minor strokes or TIA's found no evidence of a erly women but not men. 17, 18 Silent cerebrovascular J-shaped relationship between BP and stroke recurdamage may exhibit a J-shaped relationship to a nocrence but a direct and continuous one over a wide turnal BP fall with maximal damage occurring in the BP range.
8 While the treatment of severe hypertenextreme and 'non-dippers' and least in the moderate sion in stroke survivors (DBP Ͼ115 mm Hg) appears 'dippers'. 19 More recently changes in circadian BP undoubtedly of benefit, the few studies of antihyperfollowing stroke have been examined and attenuated tensive therapy in survivors with mild to moderate day-night BP differences have been found. 20, 21 In hypertension have not all shown a reduction in those, largely untreated, stroke patients with a stroke recurrence. A recent meta-analysis of studies reduced or absent nocturnal BP fall, prognosis may involving hypertensive stroke and TIA patients sugbe worse than in those patients demonstrating a fall in nocturnal compared to daytime BP. 22 Such considerations suggest that the effects of antihypertensive therapy on circadian BP variability may be of Correspondence: MD Fotherby therapeutic relevance. Azuma et al 11 report the 2-10 months of their first stroke to a calcium channel blocker ± bendrofluazide or matching placebo. effects of treatment with a beta-blocker (acebutolol), a calcium antagonist (slow release nifedipine) and
Again measured outcomes will include stroke recurrence and major cardiovascular events. However, an ACE inhibitor (captopril) on 24-h non-invasively monitored BP in a small group of patients more than even when these studies have been reported, many issues will remain; for example should treatment be 1 month following their stroke. There were significant decreases in mean 24-h systolic and diastolic started early following stroke (ie, within the first 2 weeks) or only after several weeks, does it matter BP will all treatments, but the effect on BP at different time periods throughout the 24-h appeared to which antihypertensive therapy is used, how far should BP be lowered and does the type of stroke differ. The beta-blocker did not significantly affect the nocturnal or morning BP whilst the calcium or degree of cerebrovascular disease matter? There is much still to be done in this previously negchannel blocker reduced both. The ACE inhibitor did lower the morning BP, but appeared not to have lected area. significant effects on the overall circadian BP pattern. Whether such drug induced changes in the 24- other about to start should provide some answers.
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The protection against recurrent stroke study perindopril and indapamide or matching placebo in 193-196. normotensive and hypertensive patients with a his- tensive stroke survivors will be randomised within
